| CTS | Cysteine Cathepsins |
| LOH | Loss of Heterozygosity |
| BID | BH3 Interacting Domain Death Agonist |
| BAK | BCL2 Antagonist/Killer |
| BAX | BCL2 Associated X, Apoptosis Regulator |
| XIAP | X-Chromosome-Linked Inhibitor of Apoptosis |
| ROS | Reactive Oxygen Species |
| TNF | Tumor Necrosis Factor |
| LAMP-1 | Lysosome-Associated Membrane Protein-1 |
| HRPC | Hormone-Refractory Prostate Cancer |
| NSCLC | Non-Small Cell Lung Cancer |
| E-64-d | Protease Inhibitor |
| EMT | Epithelial–Mesenchymal Transition |
| MET | Mesenchymal-Epithelial Transition |
| SNAIL1 | Snail Family Transcriptional Repressor 1 |
| SLUG | Snail Family Transcriptional Repressor 2 |
| ZEB | Zinc Finger E-Box Binding Homeobox |
| NF-κB | Nuclear Factor Kappa B |
| PI3K | Phosphatidylinositol 3-Kinase |
| MMP | Matrix Metalloproteinase |
| ECM | Extracellular Matrix |
| MV | Microvesicle |
| KGP94 | Cathpesin L Inhibitor |